RE 104
Alternative Names: RE-104Latest Information Update: 04 Jul 2024
At a glance
- Originator Re-Pharm
- Class Antidepressants
- Mechanism of Action Serotonin 5-HT2A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Postnatal depression